CornerCap Investment Counsel »

Arcus Biosciences Incorporated shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $244k 13k 19.10
2023-09-30 $230k 13k 17.95
2023-06-30 $262k 13k 20.31
2023-03-31 $226k 12k 18.24
2022-09-30 $213k 8.1k 26.17

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated